trending Market Intelligence /marketintelligence/en/news-insights/trending/eonKVuloacFYsVWho72qJg2 content esgSubNav
In This List

XTL Biopharmaceuticals announces stock split

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


XTL Biopharmaceuticals announces stock split

XTL Biopharmaceuticals Ltd. announced a stock split that will take effect Feb. 10.

XTL Biopharmaceuticals' depositary share will represent 100 ordinary shares of the company at that date as opposed to 20 ordinary shares previously.

The split will help the company regain compliance with Nasdaq's listing requirements.